Author

Lily Mak

Observed institution: Gilead Sciences (United States)

OpenAlex ID: A5099638210

Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants

2024 · Olena Anoshchenko, Mazin Abdelghany, et al. · Clinical Pharmacology & Therapeutics · 11

Clinical Evaluation of Drug–Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent

2025 · Chi‐Chi Peng, Rita Humeniuk, et al. · Clinical Pharmacology & Therapeutics · 3

First-In-Human, Proof-of-Mechanism Phase 1 Study of the Oral MRGPRX2 Antagonist SEP-631 Utilizing Short Wave Infrared Imaging to Assess Response to an Icatibant Skin Challenge

2026 · Jody Tversky, Christina Chang, et al. · Journal of Allergy and Clinical Immunology

Works count: 3

Citation count: 14

H-index: 2

I10-index: 1